Ticker
GALTCompany Name
GALECTIN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Debt Paydown Yield | Market Capitalization | Net Cash Flow - Issuance (Repayment) of Debt Securities |
---|---|---|---|
6/30/2025 | -8.72% | $ 240.87M | $ 21M |
3/31/2025 | -23.94% | $ 83.54M | $ 20M |
12/31/2024 | -38.92% | $ 77.08M | $ 30M |
9/30/2024 | -23.18% | $ 172.6M | $ 40M |
6/30/2024 | -21.41% | $ 140.13M | $ 30M |
3/31/2024 | -15.78% | $ 190.17M | $ 30M |
12/31/2023 | -20.28% | $ 147.95M | $ 30M |
9/30/2023 | -24.87% | $ 120.6M | $ 30M |
6/30/2023 | -33.79% | $ 88.78M | $ 30M |
3/31/2023 | -20.47% | $ 97.71M | $ 20M |
(-1 * CF - Debt) / Market Cap
(=) Debt Paydown Yield
Debt Paydown Yield for GALECTIN THERAPEUTICS INC is calculated as follows: (-1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 143.83M ]
(=) Debt Paydown Yield [ 0% ]
Minimum
Mar 31, 2022
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 3.29K |
---|---|
min | -11.5% |
max | 11.49% |
average | -0.08% |
median | 0% |
std | 3.81% |